Molecular Bad Actors and Thrombosis
- 1 March 1984
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 310 (9) , 588-589
- https://doi.org/10.1056/nejm198403013100909
Abstract
The delicate balance of biochemical and cellular processes that the hemostatic mechanism comprises is dramatically highlighted by disorders that are provoked when one of the molecular components is missing or inactive. The number of participants in these processes is large and, to the dismay of nonspecialists, still growing in both quantity and complexity. The basic premise is that the procoagulant tendencies of the plasma proteins, platelets, and vascular surface are balanced by antithrombotic tendencies; yet the two opposing forces operating in concert possess the potential for a highly focal and limited response to injury that will help return the perturbed . . .Keywords
This publication has 9 references indexed in Scilit:
- Homozygous Protein C Deficiency Manifested by Massive Venous Thrombosis in the NewbornNew England Journal of Medicine, 1984
- Hereditary dysfibrinogenemia in a patient with thrombotic diseaseBlood, 1983
- Protein C and the Development of Skin Necrosis During Anticoagulant TherapyThrombosis and Haemostasis, 1983
- Deficiency of protein C in congenital thrombotic disease.Journal of Clinical Investigation, 1981
- Generation of fibrinolytic activity by infusion of activated protein C into dogs.Journal of Clinical Investigation, 1981
- Physiological activation of the human fibrinolytic system. Isolation and characterization of human plasminogen variants, Chicago I and Chicago II.Journal of Biological Chemistry, 1979
- Anticoagulant properties of bovine plasma protein C following activation by thrombinBiochemistry, 1977
- Waterfall Sequence for Intrinsic Blood ClottingScience, 1964